AVXL ANAVEX LIFE SCIENCES CORP.
company
SEC Filings & Insider Trading Activity 2026

CIK: 1314052
Health Care
Biological Products, (No Diagnostic Substances) 74 filings
Russell 2000

Latest ANAVEX LIFE SCIENCES CORP. (AVXL) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on November 25, 2025, a 10-Q quarterly report filed on February 9, 2026, an 8-K current report filed on March 25, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ANAVEX LIFE SCIENCES CORP. (AVXL) (SEC CIK 1314052), with AI-powered section-by-section summaries updated daily.

10-Q: 52
10-K: 18
8-K: 4

Latest 2026 SEC Filing Dates

10-K Annual Report
Nov 25, 2025
10-Q Quarterly Report
Feb 9, 2026
8-K Current Report
Mar 25, 2026

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Feb 25, 2026
8-K
Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Axel Paeger, MD/MBA/MBI appointed to AVXL Board effective Feb 23, 2026, filling a vacancy
  • Classified as independent director under SEC rules and Nasdaq listing standards

Item 7.01: Regulation FD Disclosure

  • Press release issued Feb 23, 2026 via Reg FD disclosure — full details in Exhibit 99.1
  • Reg FD filing ensures simultaneous public access to material nonpublic information shared with select parties

Recent 8-K Filings
Current Reports

AI-powered analysis of ANAVEX LIFE SCIENCES CORP. (AVXL) 8-K current reports disclosing material events.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Mar 25, 2026
8-K
Feb 25, 2026Analysis
10-Q
Feb 9, 2026Dec 31, 2025
8-K
Feb 9, 2026
8-K
Nov 25, 2025
10-K
Nov 25, 2025Sep 30, 2025
10-Q
Aug 12, 2025Jun 30, 2025
10-Q
May 13, 2025Mar 31, 2025
10-Q
Feb 12, 2025Dec 31, 2024
10-K
Dec 23, 2024Sep 30, 2024
10-Q
Aug 6, 2024Jun 30, 2024
10-Q
May 9, 2024Mar 31, 2024
10-Q
Feb 7, 2024Dec 31, 2023
10-K
Nov 27, 2023Sep 30, 2023
10-Q
Aug 8, 2023Jun 30, 2023
10-Q
May 9, 2023Mar 31, 2023
10-Q
Feb 7, 2023Dec 31, 2022
10-K
Nov 28, 2022Sep 30, 2022
10-Q
Aug 9, 2022Jun 30, 2022
10-Q
May 10, 2022Mar 31, 2022
10-Q
Feb 9, 2022Dec 31, 2021
10-K
Nov 24, 2021Sep 30, 2021
10-Q
Aug 12, 2021Jun 30, 2021
10-Q
May 13, 2021Mar 31, 2021
10-Q
Feb 16, 2021Dec 31, 2020

Frequently Asked Questions

What are the latest AVXL SEC filings in 2026?

ANAVEX LIFE SCIENCES CORP. (AVXL) has filed a 10-K annual report on November 25, 2025, a 10-Q quarterly report on February 9, 2026, an 8-K current report on March 25, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did AVXL file its most recent 10-K annual report?

ANAVEX LIFE SCIENCES CORP. (AVXL) filed its most recent 10-K annual report on November 25, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view AVXL 10-Q quarterly reports?

ANAVEX LIFE SCIENCES CORP. (AVXL)'s most recent 10-Q quarterly report was filed on February 9, 2026. SignalX displays every AVXL 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has AVXL filed recently?

ANAVEX LIFE SCIENCES CORP. (AVXL)'s most recent 8-K was filed on March 25, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find AVXL insider trading activity (Form 4)?

SignalX aggregates every AVXL Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does AVXL file with the SEC?

ANAVEX LIFE SCIENCES CORP. (AVXL) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AVXL filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ANAVEX LIFE SCIENCES CORP. (AVXL).

What is AVXL's SEC CIK number?

ANAVEX LIFE SCIENCES CORP. (AVXL)'s SEC CIK (Central Index Key) number is 1314052. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1314052 to look up all AVXL filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find AVXL return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from ANAVEX LIFE SCIENCES CORP. (AVXL) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of ANAVEX LIFE SCIENCES CORP. SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 74+ filings.